Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Related Posts
Alphabet to report Q3 earnings after the bell
The company faced increased antitrust activity during the quarter.
China bond yields jump to three-month highs as investors pare rate cut expectations
Chinese government bond yields moved further away from January’s historic lows amid optimism in the faltering economy and a stock market rally.
Walmart hits new highs and Target dives after earnings as rivals diverge even more
Both discounters are contending with price-conscious shoppers, but Walmart reported improving trends with discretionary merchandise.